| Autor: |
Putra-Szczepaniak, Magdalena, Reich, Adam, Jankowska-Konsur, Alina, Czarnecka, Anna, Bagłaj-Oleszczuk, Marta, Hryncewicz-Gwóźdź, Anita |
| Předmět: |
|
| Zdroj: |
Advances in Clinical & Experimental Medicine; Feb2021, Vol. 30 Issue 2, p189-195, 7p |
| Abstrakt: |
Background. Palmoplantar pustulosis (PPP) is a chronic inflammatory disease with poorly understood pathogenesis. The disease has a chronic course with improvements and exacerbations. Due to palmoplantar location, PPP has a severely negative impact on patients' quality of life. Objectives. To identify demographic and environmental factors, concomitant diseases, medications, and bacterial factors which may affect the course of PPP. Material and methods. A total of 51 patients suffering from PPP took part in the study. They were classified according to the Palmoplantar Pustulosis Psoriasis Area and Severity Index (ppPASI) into 3 groups due to the severity of the disease. Pack-year of smoking score was established as a quotient of packets smoked every 24 h and the years of being addicted. Diagnosis of metabolic syndrome was based on the IDF criteria from 2009. Chlamydia trachomatis was detected using enzyme-linked immunosorbent assay (ELISA) technique, Staphylococcus aureus by the culture swabs. Contact hypersensitivity was examined with the T.R.U.E. test. Results. Significantly high severity of PPP was observed in patients addicted to smoking with a high pack-year score (p = 0.03). Significantly lower intensity of PPP lesions was observed in patients treated with ibuprofen (p < 0.01). There was no correlation between severity of PPP skin lesions and comorbidities. Conclusions. Addiction to cigarette smoking and a high pack-year score aggravates the course of PPP. Treatment with ibuprofen can improve the course of the disease. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
